Edition:
India

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

9,888.00ZAc
5:54pm IST
Change (% chg)

-59.00 (-0.59%)
Prev Close
9,947.00
Open
10,004.00
Day's High
10,031.00
Day's Low
9,785.00
Volume
593,343
Avg. Vol
1,823,032
52-wk High
29,800.00
52-wk Low
6,899.00

Select another date:

Mon, May 20 2019

Photo

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

UPDATE 1-South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy Aspen's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

UPDATE 1-South Africa's rand recovers after U.S. jobs data, stocks slide on Aspen

JOHANNESBURG, March 8 South Africa's rand firmed on Friday, recovering from a nine-week low after sluggish U.S. employment data pushed the dollar lower and saw demand for emerging markets return.

South Africa's Aspen strikes distribution deal with U.S. drugmaker Mylan

JOHANNESBURG Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG, Nov 26 South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

Select another date: